# Study to Evaluate LPH-5 in Healthy Subjects

> **NCT06722820** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Lophora** · enrollment: 48 (estimated)

## Conditions studied

- Safety Issues
- Tolerance

## Interventions

- **DRUG:** LPH-5
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06722820
- **Lead sponsor:** Lophora
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06722820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06722820, "Study to Evaluate LPH-5 in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06722820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*